Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Clinical trial NCT06839456 · RECRUITING

Trial details

NCT number: NCT06839456
Sponsor: Children's Hospital of Philadelphia
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia High Risk Acute Lymphoblastic Leukemia High Risk Acute Myeloid Leukemia Relapse Leukemia MDS (Myelodysplastic Syndrome)Relapsed Non-Hodgkin Lymphoma Acquired Aplastic Anemia Inherited BMF Syndrome Immunodeficiency Primary Immune Regulatory Disorder Hemoglobinopathies Bone Marrow Failure

Start date: 2025-03-21
Primary completion: 2031-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.